| A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) (NCT05961787) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2022-12-30 |
| TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment (NCT04951050) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2022-02-28 |
| Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (NCT04918615) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2021-02-28 |
| Firehawk Rapamycin Target Eluting Coronary Stent North American Trial (NCT04562532) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2021-02-17 |
| Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear (NCT04538001) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2020-09-01 |
| Trial for MicroPort's DCB (NCT04386213) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2020-09-01 |
| OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation (NCT03574636) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2019-10-18 |
| Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease (NCT03287167) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2019-06-01 |
| Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation (NCT03008083) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2019-01-10 |
| Trial for MicroPort's Firesorb BVS: FUTURE-III (NCT03660202) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2019-01-01 |
| Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s) (NCT03040934) | Shanghai MicroPort Medical (Group) Co., Ltd. | 2017-11-10 |